Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2012);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10,673;Q1;193;26;54;3020;1319;54;24,60;116,15;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10,673;Q1;210;36;71;12166;1808;70;25,82;337,94;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;7,995;Q1;119;66;183;4074;2305;131;17,87;61,73;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;20425;Nature Reviews Drug Discovery;journal;14741776;6,540;Q1;289;233;693;7888;7355;445;16,28;33,85;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;5,103;Q1;201;88;255;5885;3006;239;11,07;66,88;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;18017;Neuropsychopharmacology;journal;0893133X;4,716;Q1;204;304;802;18513;6635;744;9,14;60,90;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X;4,499;Q1;278;180;385;22774;5309;337;15,11;126,52;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
8;21195;Pharmacology and Therapeutics;journal;01637258;3,668;Q1;180;109;304;19821;3035;297;9,40;181,84;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;26371;Natural Product Reports;journal;02650568, 14604752;3,623;Q1;157;72;243;10736;2446;231;10,23;149,11;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3,403;Q1;194;296;916;30543;6337;896;6,41;103,19;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;12611;Drug Resistance Updates;journal;13687646, 15322084;3,276;Q1;100;26;62;3117;628;60;10,68;119,88;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;12455;Molecular Therapy;journal;15250024, 15250016;3,234;Q1;158;279;835;11095;5591;702;8,02;39,77;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;4400151524;Particle and Fibre Toxicology;journal;17438977;3,221;Q1;83;49;106;2648;1075;101;10,71;54,04;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
14;18148;Pain;journal;03043959;3,094;Q1;238;371;1187;15117;6048;882;6,50;40,75;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;110172;Progress in Drug Research;book series;0071786X;3,084;Q1;38;0;15;0;90;13;6,92;0,00;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
16;20681;Current Opinion in Pharmacology;journal;14714892;2,890;Q1;120;116;340;5865;2302;312;6,40;50,56;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2,809;Q1;166;198;537;8186;2609;503;5,04;41,34;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;5100155080;Neurotherapeutics;journal;19337213;2,526;Q1;100;69;196;6439;1347;182;7,45;93,32;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;19907;Medicinal Research Reviews;journal;01986325, 10981128;2,488;Q1;119;38;72;6847;587;67;7,69;180,18;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
20;19963;Molecular Pharmacology;journal;15210111, 0026895X;2,471;Q1;186;209;730;9343;3872;706;5,04;44,70;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
21;23010;Journal of Controlled Release;journal;01683659;2,454;Q1;237;531;1336;30674;8614;1241;6,22;57,77;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
22;24749;Addiction Biology;journal;13556215, 13691600;2,436;Q1;70;93;154;5233;863;149;5,55;56,27;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
23;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2,401;Q1;127;140;392;6945;1985;371;5,16;49,61;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
24;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;2,379;Q1;106;162;255;6872;2194;246;8,61;42,42;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
25;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2,363;Q1;232;1005;2630;33968;13488;2456;5,33;33,80;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2,343;Q1;240;921;2364;43382;13829;2316;6,04;47,10;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
27;20435;Neuropharmacology;journal;00283908;2,315;Q1;150;411;806;31524;4099;783;4,46;76,70;United Kingdom;Elsevier Ltd.;1962-ongoing;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
28;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2,283;Q1;172;534;1579;13760;7636;1218;6,34;25,77;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
29;20624;Clinical Pharmacokinetics;journal;03125963;2,254;Q1;150;59;183;4432;1206;160;7,56;75,12;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;19427;Advances in Pharmacology;book series;10543589;2,207;Q1;68;34;85;5270;420;61;7,49;155,00;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;21000196010;Topics in antiviral medicine;journal;21615853;2,177;Q1;37;22;56;346;294;55;5,80;15,73;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
32;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2,157;Q1;110;525;1019;23887;5447;980;5,24;45,50;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
33;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2,155;Q1;173;273;852;8799;4540;692;6,45;32,23;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2,152;Q1;110;360;679;16010;4046;656;5,49;44,47;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
35;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;2,131;Q1;93;133;383;7647;1902;360;5,09;57,50;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
36;5400152706;Nanotoxicology;journal;17435390, 17435404;2,104;Q1;72;76;122;3587;893;115;7,34;47,20;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
37;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2,064;Q1;161;260;862;11617;4564;851;5,31;44,68;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
38;23916;Environmental Pollution;journal;02697491, 18736424;2,038;Q1;194;435;1433;20329;6269;1399;4,15;46,73;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
39;21782;Psychopharmacology;journal;00333158;2,038;Q1;181;419;1077;23884;4691;1025;4,48;57,00;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
40;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2,025;Q1;98;42;118;5856;770;108;7,14;139,43;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
41;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1,990;Q1;138;235;589;9095;3199;575;4,71;38,70;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
42;21196;Drug Discovery Today;journal;13596446;1,967;Q1;157;170;437;10127;2872;401;6,72;59,57;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
43;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1,963;Q1;102;115;369;5245;1821;362;4,46;45,61;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
44;15576;European Neuropsychopharmacology;journal;0924977X;1,955;Q1;100;110;303;5208;1407;294;4,85;47,35;Netherlands;Elsevier BV;1990-ongoing;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
45;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1,905;Q1;75;0;138;0;735;128;5,06;0,00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
46;4000148019;AAPS Journal;journal;15507416;1,902;Q1;96;100;236;4246;1358;220;4,60;42,46;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
47;84948;Expert Opinion on Drug Delivery;journal;17425247;1,895;Q1;88;120;291;10320;1769;287;5,87;86,00;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
48;21123;Pharmaceutical Research;journal;07248741, 1573904X;1,895;Q1;191;288;804;11482;4566;749;5,89;39,87;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
49;20063;Biochemical Pharmacology;journal;00062952;1,877;Q1;181;357;1102;20250;5838;981;5,72;56,72;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
50;4700152903;Forensic Toxicology;journal;18608965, 18608973;1,845;Q1;30;29;61;567;168;54;3,36;19,55;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
51;25218;Toxicological Sciences;journal;10960929, 10966080;1,812;Q1;164;302;842;13655;4178;788;4,90;45,22;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
52;20084;British Journal of Pharmacology;journal;00071188;1,811;Q1;190;564;1533;36599;7249;1451;5,31;64,89;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
53;21165;PharmacoEconomics;journal;11707690;1,798;Q1;91;94;287;3897;980;238;3,55;41,46;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
54;26380;Drug and Alcohol Dependence;journal;03768716;1,794;Q1;151;325;832;15795;3261;801;3,55;48,60;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
55;29311;Current Cancer Drug Targets;journal;15680096;1,789;Q1;85;89;240;9901;1155;222;4,70;111,25;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
56;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1,788;Q1;78;140;328;11271;1485;322;4,41;80,51;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
57;21237;Drug Safety;journal;01145916;1,778;Q1;115;112;296;4616;1165;233;4,37;41,21;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
58;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1,693;Q1;143;259;750;11794;2852;713;3,77;45,54;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
59;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1,689;Q1;209;351;1318;14572;5731;1279;4,43;41,52;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
60;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1,688;Q1;114;195;853;11236;2960;653;4,24;57,62;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
61;144771;Clinical Trials;journal;17407753, 17407745;1,648;Q1;55;89;231;2079;462;184;2,30;23,36;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
62;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;1,628;Q1;64;109;329;4578;2337;323;7,50;42,00;United States;American Scientific Publishers;2007-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
63;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1,613;Q1;81;152;380;17166;1680;349;4,14;112,93;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
64;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1,604;Q1;59;164;173;6428;793;153;5,37;39,20;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
65;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1,604;Q1;161;284;895;9403;3813;883;3,85;33,11;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
66;19600166320;Protein & Cell;journal;16748018, 1674800X;1,603;Q1;48;118;261;5382;752;241;3,12;45,61;Germany;Springer Verlag;2010-ongoing;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
67;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1,599;Q1;78;69;148;2816;768;141;5,39;40,81;United Kingdom;Nature Publishing Group;2001-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
68;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1,578;Q1;153;327;888;16585;4078;852;4,58;50,72;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
69;22072;Current Gene Therapy;journal;15665232;1,565;Q1;65;45;142;5121;695;127;6,09;113,80;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2)"
70;19600166302;Current molecular pharmacology;journal;18744702;1,560;Q1;34;39;57;3998;284;55;4,70;102,51;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
71;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1,556;Q1;89;18;104;2906;550;99;5,32;161,44;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
72;22454;International Journal of Pharmaceutics;journal;03785173;1,552;Q1;190;724;1810;26185;8114;1783;4,19;36,17;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
73;23488;Current Medicinal Chemistry;journal;09298673;1,538;Q1;158;505;999;59230;5078;962;4,74;117,29;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
74;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1,518;Q1;52;217;289;4951;1031;286;3,60;22,82;United States;American Chemical Society;2010-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
75;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1,515;Q1;70;24;66;1925;345;64;4,74;80,21;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
76;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1,510;Q1;64;97;173;6255;747;161;3,72;64,48;Germany;Springer Verlag;2006-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
77;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1,497;Q1;89;80;261;3263;1010;254;4,18;40,79;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
78;21169;Pharmacological Research;journal;10436618, 10961186;1,493;Q1;118;136;401;7748;2168;386;5,40;56,97;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
79;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1,492;Q1;78;123;214;9055;771;186;4,15;73,62;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
80;21351;Expert Opinion on Investigational Drugs;journal;13543784;1,486;Q1;94;165;448;12444;1985;431;4,46;75,42;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
81;28792;Cancer Biology and Therapy;journal;15384047;1,478;Q1;101;181;990;7253;2837;764;3,66;40,07;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
82;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1,472;Q1;82;58;150;2870;520;150;3,05;49,48;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
83;20679;Current Opinion in Investigational Drugs;journal;14724472;1,470;Q1;71;0;275;0;1096;259;4,13;0,00;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
84;145164;Human Genomics;journal;14739542, 14797364;1,462;Q1;49;26;112;1348;389;95;3,06;51,85;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
85;23109;Journal of Psychopharmacology;journal;02698811;1,443;Q1;106;176;535;11248;1986;489;3,95;63,91;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
86;23053;Journal of Natural Products;journal;01633864, 15206025;1,428;Q1;124;347;1239;10629;4355;1194;3,63;30,63;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
87;19617;Antiviral Research;journal;01663542;1,421;Q1;108;174;497;9064;2187;483;4,55;52,09;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
88;23079;Journal of Pharmaceutical Sciences;journal;00223549;1,419;Q1;159;436;1318;16753;5082;1256;3,87;38,42;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
89;12331;Current Topics in Medicinal Chemistry;journal;15680266;1,409;Q1;104;233;518;22139;1969;439;4,30;95,02;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
90;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1,382;Q1;144;272;682;15171;2784;648;4,06;55,78;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
91;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1,372;Q1;131;246;668;8042;2410;517;4,35;32,69;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
92;18966;Mutagenesis;journal;02678357, 14643804;1,353;Q1;82;90;245;4553;939;231;3,94;50,59;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
93;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1,347;Q1;81;85;206;2976;628;191;3,30;35,01;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
94;20664;Current Drug Targets;journal;13894501;1,332;Q1;92;194;482;18772;1835;435;4,58;96,76;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
95;20783;Expert Review of Vaccines;journal;14760584;1,331;Q1;75;153;468;8819;1773;377;4,79;57,64;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
96;21353;Expert Opinion on Therapeutic Patents;journal;13543776;1,330;Q1;61;100;319;7922;1148;312;3,54;79,22;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
97;26512;Tetrahedron;journal;00404020;1,329;Q1;209;1265;3610;64463;11414;3555;3,13;50,96;United Kingdom;Elsevier Ltd.;1957-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
98;21790;Antiviral Therapy;journal;13596535;1,303;Q1;78;192;444;7141;1465;425;3,43;37,19;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
99;25219;Toxicology;journal;0300483X;1,303;Q1;143;198;698;9393;2986;658;4,68;47,44;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
100;24763;Addictive Behaviors;journal;03064603;1,282;Q1;114;231;615;9652;1613;610;2,41;41,78;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
101;20682;Current Pharmaceutical Design;journal;13816128;1,280;Q1;140;587;1162;65504;4758;1056;4,07;111,59;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
102;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1,271;Q1;119;255;578;10045;2296;563;3,53;39,39;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
103;20049;Behavioural Pharmacology;journal;14735849, 09558810;1,269;Q1;76;85;231;4860;649;228;2,44;57,18;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
104;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1,262;Q1;60;0;166;0;642;159;3,93;0,00;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
105;13250;Expert Opinion on Biological Therapy;journal;14712598;1,247;Q1;75;192;432;11824;1776;422;4,23;61,58;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
106;24604;Archives of Toxicology;journal;14320738, 03405761;1,233;Q1;96;186;379;9470;1831;327;6,48;50,91;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
107;25075;Ecotoxicology;journal;09639292, 15733017;1,218;Q1;81;231;506;11479;1475;499;3,03;49,69;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
108;18071;Neurotoxicity Research;journal;10298428;1,217;Q1;65;69;237;5163;833;231;3,25;74,83;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
109;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1,204;Q1;142;751;2598;28941;8831;2556;3,26;38,54;United Kingdom;Elsevier Ltd.;1993-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
110;17464;European Journal of Medicinal Chemistry;journal;02235234;1,204;Q1;135;614;2067;23730;8852;2056;3,99;38,65;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
111;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1,198;Q1;44;91;244;5984;724;227;3,70;65,76;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
112;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1,198;Q1;114;447;1330;12703;4545;1310;3,46;28,42;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
113;24028;Reproductive Toxicology;journal;08906238;1,198;Q1;99;157;397;7631;1458;366;3,56;48,61;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q1)
114;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1,197;Q1;126;274;765;17137;2314;756;2,90;62,54;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
115;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1,196;Q1;63;65;195;2405;577;161;3,16;37,00;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
116;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1,177;Q1;55;74;215;1730;503;134;3,11;23,38;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
117;19700175004;Open Medicinal Chemistry Journal;journal;18741045;1,174;Q1;15;4;20;140;81;18;4,76;35,00;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
118;16088;Journal of Nanobiotechnology;journal;14773155;1,169;Q1;57;47;100;1852;464;100;4,63;39,40;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
119;23015;Journal of Ethnopharmacology;journal;03788741;1,157;Q1;170;670;1750;28868;6699;1735;3,46;43,09;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
120;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;1,154;Q1;70;82;362;3570;1071;353;2,87;43,54;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
121;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1,146;Q1;89;118;293;4396;826;259;2,34;37,25;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
122;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1,145;Q1;116;115;315;5042;718;303;2,03;43,84;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
123;4400151608;ChemMedChem;journal;18607187, 18607179;1,142;Q1;92;219;658;10563;2017;626;3,11;48,23;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
124;20663;Current Drug Metabolism;journal;13892002;1,139;Q1;97;132;260;14321;1275;230;5,15;108,49;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmacology (Q1); Clinical Biochemistry (Q2)"
125;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;1,129;Q1;61;46;124;1940;388;114;3,71;42,17;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
126;25096;Food and Chemical Toxicology;journal;02786915;1,126;Q1;149;712;1476;28253;5798;1434;3,71;39,68;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
127;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1,120;Q1;69;12;34;2387;147;34;3,27;198,92;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
128;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1,116;Q1;68;44;144;1577;457;134;3,12;35,84;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
129;22983;Journal of Clinical Pharmacology;journal;00912700;1,111;Q1;106;220;465;5697;1423;446;2,98;25,90;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
130;21455;Progress in Medicinal Chemistry;book series;00796468;1,110;Q1;33;6;27;518;59;16;5,40;86,33;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
131;20051;BioDrugs;journal;11738804;1,106;Q1;60;42;124;3053;524;122;3,65;72,69;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
132;22378;Vascular Pharmacology;journal;15371891;1,106;Q1;86;68;193;4369;598;183;3,66;64,25;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
133;22477;Investigational New Drugs;journal;01676997, 15730646;1,100;Q1;80;287;370;9018;1145;362;3,24;31,42;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
134;24652;Chemico-Biological Interactions;journal;00092797;1,099;Q1;108;98;863;4662;3126;830;3,62;47,57;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
135;26514;Tetrahedron Letters;journal;00404039;1,094;Q1;159;1687;5330;58056;14285;5278;2,69;34,41;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
136;19700176055;F1000 Biology Reports;journal;17404118;1,093;Q1;27;24;114;1414;240;113;2,12;58,92;United Kingdom;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q2); Neuroscience (miscellaneous) (Q2)"
137;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1,091;Q1;133;1506;4644;40049;12220;4557;2,58;26,59;United Kingdom;Elsevier Ltd.;1991-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
138;17067;Phytomedicine;journal;09447113;1,090;Q1;105;191;550;6338;2091;539;3,70;33,18;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
139;19700175230;Drug Design, Development and Therapy;journal;11778881;1,089;Q1;48;44;96;1938;432;92;5,21;44,05;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
140;19700174918;Clinical and Translational Science;journal;17528062, 17528054;1,086;Q1;35;80;302;1952;459;185;2,68;24,40;United States;Wiley-Blackwell;2008-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
141;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1,082;Q1;36;25;78;3030;254;75;3,16;121,20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
142;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1,081;Q1;100;287;908;8696;2871;880;3,24;30,30;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
143;18075;Neurotoxicology and Teratology;journal;08920362;1,081;Q1;89;68;212;3981;684;198;3,68;58,54;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
144;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1,081;Q1;67;53;153;3056;420;149;2,66;57,66;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
145;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;1,077;Q1;99;105;386;5514;1148;379;2,85;52,51;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
146;25240;Toxicology Letters;journal;03784274;1,072;Q2;129;332;883;14254;3216;858;3,43;42,93;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
147;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1,068;Q1;91;150;487;6060;1334;455;2,75;40,40;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
148;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1,047;Q1;54;196;432;13920;1083;337;3,18;71,02;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
149;19700194010;MedChemComm;journal;20402503, 20402511;1,042;Q1;44;212;219;8538;595;212;2,81;40,27;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
150;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1,041;Q1;100;528;476;22247;2056;475;4,13;42,13;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)"
151;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1,036;Q2;99;217;521;6510;1554;432;3,16;30,00;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
152;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1,033;Q1;89;130;252;4814;851;239;3,32;37,03;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
153;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1,027;Q2;82;121;291;11637;917;256;3,42;96,17;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cancer Research (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
154;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1,025;Q1;80;83;252;5121;808;242;3,42;61,70;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
155;22319;Toxicon;journal;00410101;1,019;Q2;116;229;830;10969;2584;795;3,32;47,90;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
156;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1,011;Q2;98;136;503;6278;1186;498;2,36;46,16;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q2)"
157;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1,009;Q2;39;74;154;4591;435;143;2,97;62,04;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
158;15581;Current Pharmaceutical Biotechnology;journal;13892010;1,008;Q1;73;269;396;24520;1183;359;3,08;91,15;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
159;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0,990;Q2;44;54;143;1992;358;139;2,74;36,89;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
160;21333;European Journal of Pharmacology;journal;00142999;0,989;Q2;167;543;2105;22221;6672;2082;3,04;40,92;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
161;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0,982;Q2;54;54;117;1656;257;111;2,10;30,67;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
162;18073;NeuroToxicology;journal;0161813X;0,982;Q2;102;175;375;10849;1194;356;2,92;61,99;Netherlands;Elsevier BV;1979-ongoing;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
163;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0,981;Q2;74;155;514;5616;1308;511;2,48;36,23;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
164;29712;Clinical Therapeutics;journal;01492918;0,976;Q2;123;214;732;7394;2055;639;2,87;34,55;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
165;23155;Current Vascular Pharmacology;journal;15701611;0,975;Q2;54;107;210;8016;723;200;3,27;74,92;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
166;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0,973;Q2;42;67;142;4860;482;127;2,93;72,54;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
167;21167;Pharmacogenomics;journal;14622416;0,968;Q2;83;210;551;8718;1850;451;4,07;41,51;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
168;17595;Journal of Biomolecular Screening;journal;10870571;0,964;Q1;69;143;383;4218;949;374;2,47;29,50;United States;Sage Science Press;1996-ongoing;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
169;19034;Microbial Drug Resistance;journal;10766294;0,963;Q2;62;86;166;2916;440;166;2,81;33,91;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)"
170;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0,951;Q2;78;124;310;4923;667;305;2,12;39,70;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Mathematics (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
171;24785;Alcohol;journal;07418329;0,949;Q2;74;85;210;4807;565;206;2,66;56,55;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
172;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0,942;Q2;72;127;369;10730;1379;363;3,60;84,49;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
173;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0,941;Q1;79;140;345;12246;1174;336;3,47;87,47;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
174;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0,936;Q2;88;136;399;5235;1220;383;2,86;38,49;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
175;13248;Experimental and Toxicologic Pathology;journal;09402993;0,925;Q2;58;130;224;5257;632;221;2,65;40,44;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q2); Cell Biology (Q3)"
176;25224;Toxicology in Vitro;journal;08872333;0,924;Q2;96;164;731;6672;2456;720;3,14;40,68;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
177;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0,920;Q2;61;52;121;2221;351;117;2,65;42,71;United States;Mary Ann Liebert Inc.;2011-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
178;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0,918;Q2;54;49;148;1826;377;136;2,29;37,27;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
179;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0,917;Q2;18;0;19;0;31;8;0,67;0,00;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
180;4400151410;Human Vaccines;journal;15548600, 15548619;0,916;Q1;49;0;580;0;1394;431;3,31;0,00;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
181;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0,906;Q2;60;199;534;6544;1336;524;2,52;32,88;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
182;20473;Life Sciences;journal;00243205;0,906;Q1;150;344;767;14270;2270;756;2,97;41,48;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
183;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0,898;Q2;43;45;138;4301;468;137;3,07;95,58;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;14805;Steroids;journal;0039128X;0,898;Q2;95;203;525;8861;1581;510;3,11;43,65;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
185;144790;Marine Drugs;journal;16603397;0,897;Q2;84;195;358;8688;1694;355;4,81;44,55;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
186;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0,896;Q1;58;80;207;3346;528;175;2,58;41,83;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
187;22432;International Immunopharmacology;journal;15675769;0,892;Q2;98;271;787;10717;2346;763;2,84;39,55;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
188;25109;Inhalation Toxicology;journal;08958378, 10917691;0,889;Q2;77;102;308;4276;674;298;2,29;41,92;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
189;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0,886;Q2;64;52;212;1798;474;205;2,27;34,58;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
190;25125;Journal of Analytical Toxicology;journal;01464760;0,881;Q2;69;97;289;2112;608;272;2,57;21,77;United States;Perston Publications, Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
191;15840;Journal of Antibiotics;journal;00218820;0,877;Q2;73;127;414;2811;867;377;2,52;22,13;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
192;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0,876;Q2;83;116;317;5510;728;313;2,35;47,50;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;25214;Toxicologic Pathology;journal;15331601, 01926233;0,874;Q2;96;123;315;5559;761;284;2,50;45,20;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
194;16836;BMC Chemical Biology;journal;14726769;0,860;Q2;19;5;16;189;44;16;2,89;37,80;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
195;29053;Molecular Diversity;journal;1573501X, 13811991;0,852;Q2;54;76;237;2527;782;226;3,18;33,25;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
196;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0,841;Q2;87;72;277;3003;746;265;2,52;41,71;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
197;130063;Pharmacological Reports;journal;17341140, 22995684;0,838;Q2;71;161;436;6871;1216;418;2,53;42,68;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
198;4000150314;Chemical Biology and Drug Design;journal;17470277;0,837;-;71;218;438;8263;1166;418;2,84;37,90;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q3)"
199;19984;Assay and Drug Development Technologies;journal;1540658X;0,834;Q2;52;89;261;1729;305;149;2,03;19,43;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
200;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0,833;Q2;78;194;587;8128;1470;576;2,34;41,90;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
201;25093;Environmental Toxicology;journal;15227278, 15204081;0,830;Q2;69;80;208;3426;513;206;2,48;42,83;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
202;4700152848;PPAR Research;journal;16874757, 16874765;0,830;Q2;40;86;115;5992;301;107;2,97;69,67;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
203;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0,826;Q2;37;92;242;4922;570;199;3,06;53,50;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
204;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0,826;Q2;18;0;21;0;51;21;2,56;0,00;United Kingdom;BioMed Central;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
205;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0,819;Q2;87;133;328;5646;964;313;2,78;42,45;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
206;6400153120;Chinese Medicine;journal;17498546;0,813;Q2;34;28;109;951;367;100;3,71;33,96;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
207;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0,810;Q2;76;108;276;5571;805;271;2,75;51,58;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
208;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0,810;Q2;90;162;418;7226;1120;389;2,66;44,60;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
209;21229;Drug News and Perspectives;journal;02140934;0,808;Q2;47;0;143;0;316;139;2,90;0,00;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
210;16573;Phytotherapy Research;journal;10991573, 0951418X;0,807;Q2;112;305;968;9603;2598;920;2,58;31,49;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
211;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0,806;Q1;44;150;276;4689;730;251;3,21;31,26;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
212;22410;Inflammation Research;journal;1420908X, 10233830;0,806;Q2;82;161;441;6254;967;433;2,13;38,84;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
213;19374;AAPS PharmSciTech;journal;15221059, 15309932;0,804;Q1;79;164;496;5176;1150;487;2,15;31,56;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
214;130025;Current Drug Delivery;journal;15672018;0,804;Q1;54;64;183;3473;489;179;3,00;54,27;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
215;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0,804;Q2;78;166;444;6188;878;442;1,92;37,28;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
216;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0,803;Q2;29;25;58;3322;181;58;3,05;132,88;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
217;130047;Current Drug Discovery Technologies;journal;15701638;0,801;Q2;38;34;95;2615;283;87;2,64;76,91;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
218;20602;Clinical Neuropharmacology;journal;03625664;0,800;Q2;74;63;236;1632;606;208;2,65;25,90;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
219;14990;Current Neuropharmacology;journal;1570159X;0,799;Q2;58;37;156;4661;430;147;2,36;125,97;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q2); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
220;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0,793;Q2;43;84;206;1541;187;182;0,85;18,35;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
221;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0,793;Q1;69;46;127;2461;354;124;2,72;53,50;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
222;26370;Molecules;journal;14203049;0,792;Q1;116;1060;1817;41684;5723;1803;2,89;39,32;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
223;18077;Fitoterapia;journal;0367326X;0,791;Q2;90;254;536;7559;1562;532;2,88;29,76;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
224;26767;Altex;journal;1868596X, 18688551;0,790;Q2;45;37;93;1481;280;78;4,15;40,03;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
225;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0,789;Q2;40;32;95;1973;296;89;4,12;61,66;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2)"
226;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0,785;Q2;53;110;267;2867;534;261;1,93;26,06;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
227;16533;Phytochemical Analysis;journal;09580344, 10991565;0,784;Q2;63;96;221;2359;584;216;2,86;24,57;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Molecular Medicine (Q3)"
228;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0,783;Q1;25;22;46;2367;110;44;2,54;107,59;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
229;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0,782;Q2;50;91;275;8586;634;273;2,46;94,35;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q2)
230;25898;Journal of Peptide Science;journal;10752617, 10991387;0,780;Q2;60;101;322;3701;669;314;2,15;36,64;United States;John Wiley & Sons Inc.;1995-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
231;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0,779;Q2;95;154;552;7366;1204;509;2,40;47,83;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
232;4000148406;Clinical Toxicology;journal;15563650;0,776;Q2;85;153;441;2971;1082;355;2,97;19,42;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
233;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0,774;Q2;30;44;127;1846;299;122;2,76;41,95;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
234;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0,762;Q1;25;22;68;570;102;61;1,85;25,91;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
235;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0,760;Q2;33;66;145;1136;168;134;1,09;17,21;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
236;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0,756;Q2;55;93;253;3431;546;238;2,14;36,89;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
237;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0,756;Q2;69;262;787;16293;2075;738;2,78;62,19;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
238;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0,755;Q1;27;39;46;2240;104;40;2,60;57,44;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science (Q1)
239;23942;Biomedical Chromatography;journal;10990801, 02693879;0,752;Q2;58;220;519;5504;1113;500;2,19;25,02;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
240;24578;Mathematical Medicine and Biology;journal;14778599;0,752;Q2;40;21;50;741;117;49;2,13;35,29;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
241;21744;Planta Medica;journal;14390221, 00320943;0,749;Q1;103;266;832;7857;2170;797;2,64;29,54;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
242;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0,739;Q2;56;34;120;1713;354;119;2,68;50,38;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
243;23039;Journal of Liposome Research;journal;08982104, 15322394;0,736;Q1;44;36;99;1468;230;97;2,14;40,78;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
244;20570;Chemotherapy;journal;00093157, 14219794;0,735;Q2;49;62;177;2114;421;172;2,56;34,10;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0,734;Q2;46;23;59;1092;134;55;2,18;47,48;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
246;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0,731;Q1;104;352;1050;11073;2430;1014;2,24;31,46;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
247;19700188352;Toxins;journal;20726651;0,731;Q2;56;90;261;6168;649;258;2,55;68,53;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
248;4000151703;Core Evidence;journal;15551741, 1555175X;0,725;Q2;19;12;38;757;103;36;2,56;63,08;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
249;14822;Xenobiotica;journal;00498254, 13665928;0,723;Q2;75;123;276;4392;620;270;2,15;35,71;United Kingdom;Taylor & Francis;1971-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
250;21100214102;Frontiers in Pharmacology;journal;16639812;0,717;Q2;62;207;130;17795;312;126;2,48;85,97;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
251;28620;Biomedicine and Pharmacotherapy;journal;07533322;0,713;Q2;78;101;339;3533;829;331;2,45;34,98;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
252;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0,712;Q2;80;138;403;5417;791;389;2,06;39,25;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
253;19443;American Journal of Health-System Pharmacy;journal;10792082;0,700;Q2;87;375;1169;4867;1482;662;1,94;12,98;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
254;23050;Journal of Microencapsulation;journal;02652048, 14645246;0,696;Q1;70;81;244;3353;529;242;1,98;41,40;United Kingdom;Taylor & Francis;1984-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
255;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0,691;Q2;80;146;418;5721;981;400;2,43;39,18;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
256;25095;Environmental Toxicology and Pharmacology;journal;13826689;0,690;Q2;72;172;345;7187;796;343;2,41;41,78;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
257;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0,690;Q2;65;131;262;3646;612;255;2,42;27,83;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
258;19700178100;Nanotechnology, Science and Applications;journal;11778903;0,689;Q1;23;8;27;480;79;27;2,93;60,00;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Nanoscience and Nanotechnology (Q2)"
259;19300156901;Dose-Response;journal;15593258;0,688;Q2;30;44;104;1926;246;101;2,01;43,77;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
260;24071;Metal-Based Drugs;journal;07930291, 16875486;0,684;Q2;33;0;8;0;27;8;4,20;0,00;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Pharmacology (Q2); Toxicology (Q2)"
261;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0,683;Q2;30;43;81;2507;183;80;1,94;58,30;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
262;20770;Drug Delivery;journal;10717544;0,680;Q1;52;44;196;1812;421;185;2,38;41,18;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
263;22575;Cardiovascular Toxicology;journal;15307905;0,679;Q2;47;45;105;1779;265;100;2,74;39,53;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
264;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0,676;Q2;7;2;10;44;24;9;2,67;22,00;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Biophysics (Q2); Pharmacology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
265;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0,671;Q1;54;54;142;1771;343;141;2,51;32,80;United States;John Wiley & Sons Inc.;1979-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
266;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0,671;Q1;107;187;466;8313;1113;459;2,36;44,45;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
267;5800173401;Current Bioactive Compounds;journal;15734072;0,660;Q1;21;46;80;2983;120;71;0,89;64,85;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
268;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0,660;Q1;37;1106;962;27913;1867;959;1,77;25,24;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q1); Pharmacology (Q2)"
269;19700188217;Bioanalysis;journal;17576180, 17576199;0,658;Q1;51;323;601;9000;1224;527;2,29;27,86;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
270;16948;Chirality;journal;1520636X, 08990042;0,656;Q2;73;141;423;5579;1002;419;2,13;39,57;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
271;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0,651;Q1;29;56;211;1294;386;203;2,35;23,11;India;Medknow Publications;2008-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
272;20634;Journal of Texture Studies;journal;00224901;0,650;Q1;48;47;144;1574;193;142;1,27;33,49;United States;Wiley-Blackwell;1969-ongoing;"Pharmaceutical Science (Q1); Food Science (Q2)"
273;10900153302;Biomarker Insights;journal;11772719;0,648;Q2;24;16;45;759;108;44;2,47;47,44;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
274;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0,648;Q2;77;175;378;8614;758;364;1,88;49,22;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
275;25789;Bioorganic Chemistry;journal;00452068, 10902120;0,638;Q2;50;39;97;1967;185;96;1,80;50,44;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
276;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0,638;Q2;63;440;845;8527;1197;839;1,29;19,38;Germany;Springer Verlag;1966-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
277;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;0,638;Q2;27;32;4;2137;6;3;2,00;66,78;Netherlands;Elsevier BV;2011-ongoing;"Infectious Diseases (Q2); Parasitology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
278;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0,628;Q2;84;232;882;6333;1572;874;1,77;27,30;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
279;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0,627;Q2;26;50;34;1950;38;28;0,40;39,00;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
280;20027;BMC Pharmacology;journal;14712210;0,623;Q2;38;8;46;343;127;45;3,10;42,88;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
281;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0,619;Q2;22;9;55;538;78;48;1,73;59,78;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q2); Molecular Medicine (Q3)"
282;17500155003;Records of Natural Products;journal;13076167;0,618;Q2;24;59;103;1484;239;100;2,34;25,15;Turkey;ACG Publications;2009-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2); Organic Chemistry (Q3)"
283;19700175015;Infection and Drug Resistance;journal;11786973;0,614;Q2;27;20;33;953;60;31;2,04;47,65;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
284;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0,607;Q2;59;87;288;4972;607;256;2,23;57,15;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q3)"
285;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0,605;Q2;79;250;764;9032;1162;760;1,53;36,13;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
286;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0,603;Q1;13;16;29;570;36;23;1,57;35,63;United States;IPEC-Americas;2010-ongoing;"Pharmaceutical Science (Q1); Food Science (Q2)"
287;5800173383;Current Clinical Pharmacology;journal;15748847;0,600;Q1;33;34;99;2712;250;95;2,72;79,76;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
288;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0,596;Q2;36;21;93;1338;194;92;2,53;63,71;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2)"
289;21865;Fundamental and Clinical Pharmacology;journal;07673981;0,594;Q2;64;84;262;3893;542;253;2,08;46,35;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
290;21207;Drug Discovery Today: Technologies;journal;17406749;0,593;Q2;41;39;69;1904;127;61;1,91;48,82;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
291;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0,593;Q2;49;47;141;3616;262;125;2,05;76,94;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
292;16067;Reading Teacher;journal;00340561;0,591;Q2;44;82;244;1599;166;225;0,50;19,50;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
293;19700175819;Patient Preference and Adherence;journal;1177889X;0,590;Q1;37;97;139;3847;267;136;2,04;39,66;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
294;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0,589;Q2;58;140;352;2879;435;320;1,04;20,56;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
295;19956;Archiv der Pharmazie;journal;15214184, 03656233;0,584;Q2;54;106;235;3347;492;235;2,01;31,58;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
296;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0,582;Q2;50;87;182;2830;282;179;1,61;32,53;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
297;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0,578;Q3;44;132;336;4169;628;311;1,70;31,58;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
298;19700185200;Journal of Natural Medicines;journal;18610293;0,574;Q2;37;94;250;2604;482;250;1,81;27,70;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
299;19958;Archives of Pharmacal Research;journal;02536269;0,572;Q2;75;254;753;8449;1473;724;1,81;33,26;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3)"
300;19398;Acta Pharmaceutica;journal;13300075;0,569;Q2;49;40;120;1196;265;120;1,79;29,90;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
301;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0,567;Q2;45;151;527;4566;1063;504;2,23;30,24;Italy;SAGE Publications Inc.;1989-ongoing;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
302;19700175105;Open Drug Delivery Journal;journal;18741266;0,566;Q2;5;0;11;0;11;10;1,14;0,00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science (Q2)
303;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0,565;Q2;29;98;293;4108;583;290;2,17;41,92;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q2)
304;20026;BMC Clinical Pharmacology;journal;14726904;0,564;Q2;35;14;57;469;143;57;2,05;33,50;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
305;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0,562;Q3;32;47;105;2282;205;98;1,96;48,55;United States;Taylor and Francis;2004-ongoing;"Immunology (Q3); Toxicology (Q3)"
306;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0,560;Q2;37;58;117;2120;179;101;1,51;36,55;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
307;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0,552;Q3;53;72;137;2413;250;136;1,81;33,51;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
308;23412;Journal of AOAC International;journal;10603271;0,540;Q2;79;236;665;6760;968;643;1,40;28,64;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Food Science (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3)"
309;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0,540;Q2;34;37;97;2509;176;90;2,00;67,81;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
310;21194;Pharmacology;journal;00317012, 14230313;0,540;Q2;54;89;295;2925;539;267;2,05;32,87;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
311;17700156714;Pharmaceuticals;journal;14248247;0,539;Q2;44;80;289;5945;488;284;1,72;74,31;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q2); Molecular Medicine (Q3)"
312;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0,535;Q2;54;110;399;3295;440;393;1,40;29,95;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
313;25171;Mycotoxin Research;journal;01787888;0,531;Q3;31;31;101;833;156;99;1,42;26,87;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
314;19900192900;Molecular Informatics;journal;18681751, 18681743;0,530;Q2;60;77;278;3316;554;268;2,46;43,06;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
315;22411;Inflammopharmacology;journal;09254692, 15685608;0,529;Q3;45;37;103;2128;254;98;1,92;57,51;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
316;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0,516;Q1;43;47;121;2311;271;121;2,13;49,17;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
317;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0,515;Q2;34;75;167;1970;301;165;1,72;26,27;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
318;4700152609;Current Computer-Aided Drug Design;journal;15734099;0,510;Q2;24;29;76;1626;134;70;1,96;56,07;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
319;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0,507;Q1;15;43;87;1387;133;87;1,65;32,26;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
320;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0,502;Q3;36;34;77;3271;170;77;1,96;96,21;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Pharmacology (Q3)"
321;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0,499;Q2;27;28;62;2250;156;60;2,86;80,36;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
322;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0,488;Q3;58;41;129;1063;148;110;1,29;25,93;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
323;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0,488;Q2;21;13;78;705;126;65;2,05;54,23;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
324;19700174969;Archives of Drug Information;journal;17535174;0,487;Q1;10;0;21;0;38;21;1,45;0,00;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
325;25864;Heterocycles;journal;03855414;0,487;Q3;61;349;970;12823;1048;963;1,13;36,74;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
326;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0,479;Q2;62;62;199;2567;362;196;1,66;41,40;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
327;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0,479;Q2;35;131;246;3646;477;246;1,49;27,83;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
328;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0,476;Q3;33;21;98;1273;159;97;1,65;60,62;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
329;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0,474;Q3;52;110;275;4431;465;268;1,66;40,28;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
330;18800156720;Dissolution Technologies;journal;1521298X;0,472;Q2;28;28;74;539;61;70;0,82;19,25;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
331;25106;Human and Experimental Toxicology;journal;09603271;0,472;Q3;71;150;459;5456;752;434;1,78;36,37;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
332;27087;American Journal of Therapeutics;journal;10752765, 15363686;0,468;Q3;55;102;332;3396;455;306;1,41;33,29;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
333;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0,468;Q2;38;74;170;3662;184;166;1,39;49,49;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
334;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0,462;Q1;52;203;641;3487;702;541;1,16;17,18;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
335;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0,461;Q2;35;175;476;2815;545;474;1,07;16,09;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
336;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0,461;Q3;25;39;128;1114;185;119;1,55;28,56;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
337;13671;Biologicals;journal;10958320, 10451056;0,460;Q3;51;83;246;2297;497;236;2,01;27,67;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
338;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0,459;Q3;21;49;108;1271;131;107;0,93;25,94;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
339;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0,455;Q1;22;30;29;1504;61;29;2,28;50,13;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
340;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0,455;Q2;52;116;295;2987;407;271;1,34;25,75;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
341;19700175023;Journal of Toxicology;journal;16878205, 16878191;0,454;Q3;26;61;56;3651;117;56;2,09;59,85;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q3); Toxicology (Q3)"
342;4700152612;Current Nanoscience;journal;15734137;0,453;Q2;37;134;255;4764;440;251;1,55;35,55;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
343;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0,453;Q3;41;75;196;1859;295;163;1,91;24,79;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
344;17700155034;Natural product communications;journal;15559475, 1934578X;0,449;Q3;35;435;1143;10309;1426;1111;1,17;23,70;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
345;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0,448;Q3;61;132;408;4431;600;404;1,39;33,57;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
346;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0,447;Q3;35;42;51;2393;82;50;2,21;56,98;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q2); Pharmacology (Q3)"
347;19700174987;Research Journal of Toxins;journal;18193560;0,445;Q3;2;0;2;0;5;2;0,00;0,00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science (Q2); Food Science (Q2); Toxicology (Q3)"
348;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0,444;Q3;42;41;125;2004;235;122;1,78;48,88;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
349;23348;Journal of Environmental Biology;journal;23940379, 02548704;0,443;Q3;40;172;474;4990;507;469;1,05;29,01;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
350;19600162009;Advances in Molecular Toxicology;book series;18720854;0,442;Q3;10;8;22;1491;29;19;1,85;186,38;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
351;25111;International Journal of Toxicology;journal;10915818, 1092874X;0,438;Q3;51;68;212;3322;295;194;1,51;48,85;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
352;21256;Drugs of Today;journal;16993993, 16994019;0,436;Q3;46;78;229;3112;369;226;1,58;39,90;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
353;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0,436;Q2;29;121;239;2564;327;232;0,98;21,19;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
354;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0,435;Q3;36;26;64;1153;99;61;1,22;44,35;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Cancer Research (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
355;20580;Journal of Food Biochemistry;journal;01458884;0,435;Q3;40;87;297;3031;306;291;0,98;34,84;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
356;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0,434;Q3;21;22;73;2504;128;73;1,46;113,82;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
357;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0,429;Q3;30;43;112;1752;147;109;1,37;40,74;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
358;5800173386;Current Drug Safety;journal;15748863;0,428;Q3;31;64;149;2743;238;132;1,63;42,86;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
359;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0,427;Q3;23;69;179;2442;220;179;1,19;35,39;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q4)"
360;19700188360;Pharmaceutics;journal;19994923;0,426;Q2;32;35;77;1748;106;77;1,38;49,94;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q2)
361;4700152426;Current Pharmaceutical Analysis;journal;15734129;0,425;Q2;22;48;81;1591;119;80;1,45;33,15;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q4)"
362;21082;Pharmaceutical Biology;journal;13880209, 17445116;0,425;Q2;53;192;594;6963;852;586;1,59;36,27;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
363;27210;In Vivo;journal;0258851X;0,419;Q3;54;153;411;5307;608;402;1,33;34,69;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
364;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;0,415;Q3;9;16;18;670;57;18;3,17;41,88;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery (Q3)
365;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0,413;Q3;35;94;220;3660;349;209;1,70;38,94;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
366;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0,412;Q3;37;23;84;1226;110;78;1,48;53,30;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
367;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0,409;Q1;43;121;426;3262;449;426;0,83;26,96;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
368;16319;IEEE Transactions on Nanobioscience;journal;15361241;0,408;Q2;55;49;104;1754;245;102;2,00;35,80;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Nanoscience and Nanotechnology (Q3)"
369;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0,405;Q2;26;43;85;1127;113;75;1,51;26,21;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
370;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0,403;Q3;62;126;398;2728;477;371;1,23;21,65;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
371;4700152603;Medicinal Chemistry;journal;15734064;0,402;Q3;39;139;188;4664;275;185;1,51;33,55;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
372;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0,399;Q3;21;28;43;1454;59;40;1,29;51,93;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
373;29947;Journal of Chemotherapy;journal;1120009X;0,397;Q3;45;67;286;1817;323;242;1,14;27,12;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
374;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0,395;Q1;45;122;385;4116;568;380;1,44;33,74;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
375;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0,394;Q3;25;28;81;2124;125;80;1,77;75,86;United Arab Emirates;Bentham Science Publishers;2006-2015;"Pharmacology (medical) (Q2); Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3)"
376;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0,393;Q3;42;168;259;5660;373;256;1,48;33,69;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
377;19700175244;Current Radiopharmaceuticals;journal;18744710;0,392;Q3;21;45;94;2173;94;85;1,27;48,29;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
378;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0,390;Q3;38;71;168;2484;227;168;1,47;34,99;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
379;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0,388;Q2;7;7;25;387;27;25;1,08;55,29;United Kingdom;Inderscience Publishers;2010-2012;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
380;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0,387;Q2;50;101;441;2476;523;440;0,86;24,51;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
381;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0,382;Q2;13;0;9;0;14;9;0,67;0,00;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
382;19700201609;Open Natural Products Journal;journal;18748481;0,379;Q3;3;3;3;41;3;3;1,00;13,67;Netherlands;Bentham Science Publishers B.V.;2011-2014;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
383;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0,375;Q3;18;17;51;826;67;49;1,33;48,59;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q2); Pharmacology (Q3)"
384;18384;Medicinal Chemistry Research;journal;10542523;0,375;Q1;38;488;385;14154;579;382;1,42;29,00;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
385;11200153563;Drug Metabolism Letters;journal;18723128;0,374;Q2;23;29;93;1010;113;93;1,38;34,83;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
386;19400158813;HIV Therapy;journal;17584329, 17584310;0,371;Q3;12;0;108;0;70;79;1,00;0,00;United Kingdom;Future Medicine Ltd.;2009-2010;"Pharmacology (medical) (Q2); Dermatology (Q3); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Virology (Q3)"
387;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0,370;Q2;40;240;986;5254;1018;986;0,88;21,89;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
388;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0,368;Q3;17;41;90;2194;140;72;1,54;53,51;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
389;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0,368;Q3;25;65;152;1624;171;148;1,22;24,98;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
390;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0,365;Q1;32;79;196;4432;236;171;1,53;56,10;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
391;21717;Die Pharmazie;journal;00317144;0,364;Q2;56;180;448;4937;564;448;1,19;27,43;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
392;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0,364;Q2;53;78;158;2540;248;158;1,56;32,56;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
393;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0,363;Q3;12;20;89;783;76;89;0,75;39,15;United States;Academic Journals Inc.;2009-2016 (cancelled);"Health, Toxicology and Mutagenesis (Q3); Pollution (Q3); Toxicology (Q3)"
394;21192;Drug Development Research;journal;02724391, 10982299;0,358;Q3;54;61;204;2967;218;190;1,02;48,64;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
395;19700200821;Therapeutic delivery;journal;20415990, 20416008;0,357;Q2;37;132;215;8982;228;202;1,13;68,05;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q2)
396;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0,352;Q1;16;39;145;1232;134;133;0,86;31,59;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
397;29634;Journal of Negative Results in BioMedicine;journal;14775751;0,352;Q1;19;16;36;476;41;35;1,00;29,75;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
398;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0,351;Q1;37;148;484;6155;470;473;0,93;41,59;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
399;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0,348;Q3;41;87;376;2089;295;371;0,71;24,01;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
400;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0,346;Q3;27;90;213;2082;212;210;1,11;23,13;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
401;19405;Acta Poloniae Pharmaceutica;journal;00016837;0,340;Q2;35;173;319;4515;365;314;1,10;26,10;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
402;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0,340;Q2;29;528;634;11651;574;634;0,91;22,07;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q2)
403;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0,340;Q3;43;34;98;1624;137;98;1,22;47,76;United States;Begell House;1984-1990, 1992-ongoing;"Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
404;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0,340;Q1;22;48;139;1035;159;129;1,23;21,56;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
405;4500151530;Personalized Medicine;journal;17410541;0,339;Q3;24;101;242;2976;231;188;1,33;29,47;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
406;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0,336;Q3;38;43;127;4408;111;119;0,93;102,51;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Toxicology (Q3); Cancer Research (Q4)"
407;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0,333;Q2;9;7;14;130;15;14;1,07;18,57;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science (Q2)
408;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0,330;Q3;55;54;265;965;265;223;0,95;17,87;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Toxicology (Q3)"
409;22357;IDrugs : the investigational drugs journal;journal;13697056;0,330;Q3;32;0;327;0;285;324;1,11;0,00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
410;19600156803;Journal of Medicinal Plant Research;journal;19960875;0,329;Q2;47;1;1458;29;1628;1452;1,03;29,00;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
411;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0,328;Q2;19;7;22;280;24;20;1,20;40,00;United States;Springer Science + Business Media;2010-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
412;130089;Toxin Reviews;journal;15569543, 15569551;0,328;Q3;38;7;57;531;70;54;1,04;75,86;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
413;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0,326;Q3;18;16;62;503;38;49;0,68;31,44;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
414;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0,325;Q3;23;34;85;1261;134;80;1,63;37,09;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
415;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0,324;Q2;26;17;72;757;110;71;1,29;44,53;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
416;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0,324;Q2;17;17;58;741;47;58;0,47;43,59;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
417;130072;International Journal of Medicinal Mushrooms;journal;15219437;0,318;Q3;25;54;150;2199;149;148;0,91;40,72;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
418;73430;Pharmaceutical Technology;journal;15432521;0,315;Q2;35;208;606;741;98;501;0,19;3,56;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q4)"
419;22456;International Journal of Pharmacy Practice;journal;09617671;0,314;Q2;32;62;248;1664;178;222;0,68;26,84;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
420;21810;Farmacia;journal;00148237;0,311;Q2;19;96;238;1751;212;238;0,96;18,24;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
421;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0,311;Q2;46;223;530;5532;406;526;0,77;24,81;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
422;21264;Drugs in R and D;journal;11745886;0,308;Q3;39;27;59;670;75;54;1,39;24,81;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
423;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0,307;Q3;19;46;107;822;90;75;1,20;17,87;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
424;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0,306;Q3;36;114;179;2476;230;179;1,06;21,72;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
425;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0,306;Q2;33;55;209;1203;160;185;0,74;21,87;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
426;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0,303;Q3;45;61;168;1206;144;142;0,72;19,77;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
427;25144;Journal of Health Science;journal;13475207, 13449702;0,303;Q3;42;0;295;0;332;286;0,90;0,00;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
428;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0,302;Q4;26;71;149;2866;143;143;0,84;40,37;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
429;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0,301;Q3;22;19;52;653;36;49;0,63;34,37;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
430;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0,301;Q3;52;195;401;3645;412;307;1,25;18,69;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
431;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0,300;Q2;17;58;166;1217;130;163;0,93;20,98;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
432;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0,300;Q2;31;144;222;4151;200;210;0,77;28,83;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
433;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0,299;Q3;33;101;153;3150;170;152;0,99;31,19;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
434;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0,295;Q2;20;83;300;1946;304;300;0,74;23,45;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q2)
435;4700152769;Pharmacopeial Forum;journal;03634655;0,294;Q3;16;11;68;62;41;47;0,48;5,64;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Pharmacy (Q1); Drug Guides (Q3); Pharmacology (Q3)"
436;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0,291;Q2;27;44;98;1704;72;98;0,57;38,73;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
437;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0,290;Q2;35;51;141;1568;133;133;0,98;30,75;United States;Informa Healthcare;2013-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
438;22205;Saudi Pharmaceutical Journal;journal;13190164;0,289;Q2;36;48;106;1453;139;104;1,61;30,27;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
439;19383;Fluoride - Quarterly Reports;journal;00154725;0,288;Q4;41;45;100;1115;103;90;1,08;24,78;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
440;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0,288;Q2;18;59;185;1816;174;177;0,72;30,78;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
441;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0,288;Q2;15;74;169;1557;139;169;0,82;21,04;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
442;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0,285;Q3;23;75;203;4704;102;200;0,58;62,72;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
443;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0,285;Q3;47;0;140;0;128;131;0,88;0,00;Spain;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
444;130038;Letters in Drug Design and Discovery;journal;15701808;0,284;Q2;28;130;333;3925;307;331;0,93;30,19;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
445;19700174889;Drug Target Insights;journal;11773928;0,283;Q2;10;4;3;209;3;3;0,50;52,25;New Zealand;Libertas Academica;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
446;23489;Chemical Speciation and Bioavailability;journal;09542299;0,281;Q4;25;31;88;1298;53;88;0,73;41,87;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
447;19700174961;BioProcess International;trade journal;15426319;0,279;Q3;20;166;474;1428;273;454;0,60;8,60;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
448;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0,276;Q2;32;32;50;1549;58;47;1,03;48,41;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
449;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0,276;Q3;30;27;84;889;78;83;0,98;32,93;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
450;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0,273;Q2;15;0;110;0;77;110;0,76;0,00;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q2)
451;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0,273;Q2;24;302;675;7900;508;671;0,76;26,16;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q2)
452;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0,272;Q3;16;57;202;2061;133;181;0,74;36,16;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
453;19700175040;Open Vaccine Journal;journal;18750354;0,272;Q2;9;3;41;169;30;39;0,54;56,33;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Immunology (Q4)"
454;19461;Annales Pharmaceutiques Francaises;journal;00034509;0,265;Q2;22;46;131;1427;112;113;1,12;31,02;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
455;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0,264;Q3;34;37;90;997;76;88;1,09;26,95;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
456;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0,260;Q2;26;400;353;9669;257;351;0,57;24,17;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
457;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0,260;Q2;14;46;99;701;35;86;0,46;15,24;Netherlands;Elsevier BV;2009-ongoing;"Pharmacy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
458;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0,257;Q4;22;67;195;1835;106;170;0,64;27,39;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
459;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0,256;Q4;6;29;28;357;6;25;0,24;12,31;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
460;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0,253;Q3;19;47;79;1211;97;79;0,64;25,77;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
461;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0,253;Q2;11;7;31;428;40;30;1,33;61,14;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
462;21265;Drugs of the Future;journal;03778282;0,252;Q3;40;117;330;3879;191;326;0,48;33,15;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
463;35190;Revista Espanola de Quimioterapia;journal;02143429;0,250;Q3;23;53;130;1431;99;108;0,95;27,00;Spain;Sociedad Espaola de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
464;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0,250;Q2;29;266;736;6333;507;735;0,74;23,81;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
465;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0,248;Q2;25;0;637;0;495;637;0,60;0,00;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
466;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0,247;Q2;11;37;50;758;18;49;0,37;20,49;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science (Q2); Statistics and Probability (Q4)"
467;144879;Toxicology International;journal;09716580;0,247;Q4;21;56;74;1525;76;71;1,28;27,23;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
468;145693;Canadian Pharmacists Journal;journal;17151635;0,244;Q3;18;107;291;872;58;139;0,52;8,15;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
469;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0,244;Q3;26;100;109;1473;91;56;1,63;14,73;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
470;21100238633;BioImpacts;journal;22285652, 22285660;0,243;Q3;24;28;35;1203;21;32;0,66;42,96;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
471;19700175099;Topics in Medicinal Chemistry;book series;18622461;0,243;Q3;8;9;33;1105;13;25;0,35;122,78;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
472;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0,241;Q3;18;262;740;6241;373;740;0,64;23,82;India;Scientific Publishers;2008-ongoing;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
473;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0,239;Q3;26;80;192;3528;146;192;0,83;44,10;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Drug Discovery (Q3); Pharmacology (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
474;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0,238;Q2;16;20;55;606;47;55;0,49;30,30;United States;Science Publications;2007-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
475;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0,238;Q3;30;7;53;265;34;49;0,31;37,86;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
476;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0,236;Q2;79;184;535;6235;769;519;1,39;33,89;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4); Immunology (Q4); Neuroscience (miscellaneous) (Q4); Physiology (Q4)"
477;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0,235;Q3;14;34;70;2748;30;63;0,43;80,82;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
478;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0,234;Q3;11;74;43;875;44;43;0,94;11,82;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
479;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0,231;Q3;6;0;44;0;16;42;0,00;0,00;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
480;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0,231;Q3;19;33;108;944;69;106;0,69;28,61;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
481;21758;Prescrire International;journal;11677422;0,231;Q3;11;196;578;1239;108;526;0,20;6,32;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
482;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0,230;Q3;23;103;211;3071;100;209;0,36;29,82;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
483;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0,229;Q3;10;0;25;0;7;23;0,14;0,00;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
484;144963;Drug Discovery Today: Disease Models;journal;17406757;0,228;Q3;23;33;65;1830;44;56;0,76;55,45;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
485;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0,228;Q2;18;50;104;1604;80;100;0,80;32,08;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
486;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0,227;Q2;20;33;38;930;42;38;1,04;28,18;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
487;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0,225;Q2;7;0;57;0;39;52;0,75;0,00;India;Medknow Publications;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
488;19446;American Pharmaceutical Review;journal;10998012;0,224;Q3;20;82;232;1300;95;227;0,40;15,85;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
489;15600154705;EnvironmentAsia;journal;19061714;0,224;Q4;14;23;96;588;60;96;0,59;25,57;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
490;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0,224;Q2;27;137;89;2699;71;67;1,06;19,70;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q4)"
491;20578;Journal of Food and Drug Analysis;journal;10219498;0,223;Q3;41;150;151;3998;78;149;0,42;26,65;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
492;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0,223;Q3;18;15;37;352;44;37;1,19;23,47;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q3)
493;4700152607;Current Enzyme Inhibition;journal;15734080;0,221;Q3;15;12;68;1077;48;65;0,67;89,75;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
494;19700188318;International Journal of Advances in Pharmaceutical Sciences;journal;09761055;0,219;Q3;10;0;57;0;47;57;0,82;0,00;United States;Advanced Research Journals;2010-2011 (cancelled);"Pharmaceutical Science (Q3); Physical and Theoretical Chemistry (Q4)"
495;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0,219;Q2;15;32;115;800;35;99;0,41;25,00;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
496;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0,218;Q2;2;17;73;257;9;73;0,19;15,12;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
497;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0,217;Q2;28;407;326;11175;230;325;0,71;27,46;India;MediPoeia;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
498;19700175096;Pharmacognosy Journal;journal;09753575;0,217;Q3;14;89;316;2138;147;314;0,47;24,02;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
499;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0,216;Q2;18;74;441;1380;184;441;0,35;18,65;India;Rasayan Journal;2009-ongoing;"Energy (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Biochemistry (Q4)"
500;19700200880;Botulinum Journal;journal;17547326;0,215;Q2;5;10;23;188;15;20;0,79;18,80;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
501;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0,215;Q3;5;25;34;349;11;27;0,41;13,96;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
502;22854;Yakugaku Zasshi;journal;00316903;0,215;Q3;37;57;667;947;331;604;0,54;16,61;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
503;19700201333;International Journal of Drug Delivery;journal;09750215;0,213;Q3;11;20;75;553;43;75;0,57;27,65;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science (Q3)
504;79053;Natural Product Sciences;journal;12263907;0,213;Q3;22;47;160;1176;66;160;0,36;25,02;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
505;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;0,211;Q3;9;25;40;822;37;40;0,93;32,88;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science (Q3)
506;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0,211;Q3;21;76;30;1508;17;30;0,57;19,84;China;Xi'an Jiaotong University;2014-ongoing;"Pharmacy (Q2); Drug Discovery (Q3); Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
507;19700174658;Regulatory Rapporteur;trade journal;17428955;0,211;Q2;5;77;135;410;16;101;0,16;5,32;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
508;15500154707;International Journal of Biological Chemistry;journal;1819155X;0,210;Q3;12;16;62;473;78;60;1,33;29,56;Pakistan;ANSInet;2009-2016 (cancelled);"Pharmacology (Q3); Biochemistry (Q4)"
509;13718;Pharmaceutical Engineering;journal;02738139;0,210;Q3;13;58;152;365;24;134;0,11;6,29;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
510;19700200724;Der Pharmacia Lettre;journal;09755071;0,209;Q3;24;247;280;5080;128;280;0,46;20,57;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science (Q3)
511;21100470510;Drug Research;journal;21949379, 21949387;0,208;Q3;56;131;367;3007;221;357;0,63;22,95;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
512;19700201201;EPMA Journal;journal;18785077, 18785085;0,208;Q3;26;13;107;879;77;96;0,80;67,62;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q3); Drug Discovery (Q3); Health Policy (Q3)"
513;19700181240;Global Journal of Pharmacology;journal;19920075;0,208;Q2;13;28;47;899;38;47;0,81;32,11;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
514;144613;Journal of Generic Medicines;journal;17411343;0,208;Q3;14;29;111;224;33;97;0,29;7,72;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
515;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0,207;Q2;10;28;44;1200;36;44;0,82;42,86;Turkey;Marmara University;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
516;19700188355;International Journal of Phytomedicine;journal;09750185;0,206;Q4;15;63;127;1739;85;127;0,67;27,60;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
517;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0,206;Q3;15;26;90;724;46;56;0,90;27,85;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
518;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0,204;Q2;32;86;289;2692;159;278;0,51;31,30;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
519;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0,202;Q3;15;13;21;845;7;10;0,70;65,00;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
520;21811;Farmacia Hospitalaria;journal;11306343;0,201;Q3;21;116;237;2207;104;145;0,56;19,03;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
521;19700175758;International Journal of Drug Development and Research;journal;09759344;0,201;Q2;17;181;284;4692;157;283;0,55;25,92;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
522;19700175061;Open Pharmacology Journal;journal;18741436;0,201;Q3;6;5;10;400;11;10;1,80;80,00;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
523;25253;Blutalkohol;journal;00065250;0,200;Q4;13;25;111;330;8;103;0,04;13,20;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
524;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0,199;Q3;18;142;403;531;93;343;0,33;3,74;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
525;21100205919;Open Drug Discovery Journal;journal;18773818;0,199;Q4;8;0;26;0;16;23;0,70;0,00;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery (Q4)
526;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0,198;Q2;11;56;110;1220;32;91;0,35;21,79;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Business and International Management (Q3); Decision Sciences (miscellaneous) (Q3)"
527;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;00002010;0,196;-;12;0;387;0;173;386;0,45;0,00;Belgium;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
528;21100301409;Issues in Toxicology;book series;17577179;0,195;Q3;12;72;68;6768;51;64;0,77;94,00;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
529;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0,194;Q3;34;19;95;510;52;91;0,51;26,84;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
530;58808;Pharmaceutical Care and Research;journal;16712838;0,193;Q3;7;152;456;1301;44;452;0,10;8,56;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
531;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0,193;Q3;17;215;627;1830;56;612;0,10;8,51;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
532;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0,192;Q3;10;28;73;520;27;73;0,27;18,57;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
533;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0,190;Q3;18;9;45;255;33;45;0,63;28,33;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q3)
534;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0,189;Q3;8;61;79;1828;41;79;0,52;29,97;India;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
535;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0,189;Q3;15;34;7;656;2;7;0,29;19,29;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
536;21083;Pharmaceutical Care Espana;journal;11396202;0,189;Q3;9;33;78;457;11;57;0,11;13,85;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
537;20065;BioPharm International;journal;1542166X;0,188;Q3;25;143;317;583;82;286;0,27;4,08;United States;UBM Medica Periodical Publication;2002-ongoing;"Biotechnology (Q3); Pharmaceutical Science (Q3)"
538;5800173394;Current Drug Therapy;journal;15748855;0,187;Q3;14;36;98;2407;48;91;0,40;66,86;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
539;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0,187;Q3;24;552;767;11627;302;767;0,39;21,06;India;RJPBCS;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
540;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0,186;Q4;18;165;271;2291;25;270;0,06;13,88;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
541;80593;Journal of Medicinal Plants;journal;16840240;0,186;Q3;16;84;207;2762;77;207;0,35;32,88;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
542;19200156925;Cancer Therapy;journal;15439143, 15439135;0,184;Q3;8;2;68;74;32;68;0,10;37,00;United States;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
543;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0,183;Q3;19;35;109;2441;65;98;0,52;69,74;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
544;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0,183;Q3;5;3;20;238;11;19;0,38;79,33;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
545;22908;Chinese Pharmacological Bulletin;journal;10011978;0,180;Q3;15;417;1269;6771;500;1269;0,43;16,24;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
546;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0,180;Q3;10;49;138;1809;68;138;0,30;36,92;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Biotechnology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
547;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0,179;Q4;20;25;75;2498;55;74;0,96;99,92;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q3); Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Immunology and Allergy (Q4)"
548;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0,179;Q3;11;33;74;999;29;74;0,33;30,27;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
549;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0,178;Q3;12;36;64;918;29;56;0,52;25,50;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
550;19381;Acta Farmaceutica Bonaerense;journal;03262383;0,177;Q3;21;0;0;0;0;0;0,00;0,00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
551;19700200708;Journal of Global Pharma Technology;journal;09758542;0,177;Q3;10;34;185;744;87;178;0,49;21,88;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q3)
552;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;0,177;Q3;19;48;29;1654;23;26;0,88;34,46;India;OMICS Publishing Group;2010-2014 (cancelled);"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Biomedical Engineering (Q4)"
553;17700156303;Neuromethods;book series;19406045, 08932336;0,177;Q3;17;102;439;7008;114;408;0,26;68,71;United States;Humana Press, Inc.;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
554;19700175125;Internet Journal of Pharmacology;journal;15312976;0,176;Q3;7;0;71;0;40;71;0,47;0,00;United States;Internet Scientific Publications;2009-2011;Pharmacology (Q3)
555;17600155051;Drug Delivery Technology;trade journal;15372898;0,174;Q3;9;83;249;441;53;196;0,24;5,31;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q3)
556;24097;Journal of the Indian Chemical Society;journal;00194522;0,174;Q4;31;233;617;6768;200;611;0,32;29,05;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
557;22934;Chinese Pharmaceutical Journal;journal;10012494;0,173;Q3;19;498;1382;7099;285;1381;0,20;14,26;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
558;110097;Food and Drug Law Journal;journal;1064590X;0,173;Q4;18;23;92;4024;38;91;0,29;174,96;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
559;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0,173;Q3;25;172;465;2438;133;311;0,51;14,17;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
560;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0,173;Q3;3;8;13;336;9;12;0,75;42,00;New Zealand;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
561;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0,172;Q3;8;47;173;931;20;162;0,10;19,81;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
562;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0,171;Q3;19;12;102;0;37;102;0,36;0,00;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
563;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0,171;Q4;5;23;31;585;7;26;0,27;25,43;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
564;19700175071;Open Bioactive Compounds Journal;journal;18748473;0,170;Q3;5;0;6;0;9;6;0,33;0,00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Pharmaceutical Science (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
565;5800179590;Pharmacologyonline;journal;18278620;0,170;Q4;21;75;1034;2405;250;1032;0,23;32,07;Italy;SILAE;2007-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
566;19978;Ars Pharmaceutica;journal;00042927, 23409894;0,168;Q3;18;25;232;477;46;230;0,08;19,08;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
567;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0,168;Q4;12;38;105;1375;44;105;0,47;36,18;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
568;19700175149;African Journal Biomedical Research;journal;11195096;0,167;Q3;15;33;72;743;27;71;0,38;22,52;Nigeria;Bioline International;2008, 2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
569;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;0,166;Q3;11;64;46;1891;29;45;0,31;29,55;United States;Taylor and Francis;2009-2012;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4); Nanoscience and Nanotechnology (Q4)"
570;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0,166;Q4;27;84;106;2736;55;106;0,52;32,57;Iran;University of Medical Sciences;2010-ongoing;"Biochemistry (Q4); Biophysics (Q4); Clinical Biochemistry (Q4); Drug Discovery (Q4); Immunology and Microbiology (miscellaneous)  (Q4)"
571;130031;Journal of Toxicologic Pathology;journal;09149198;0,166;Q4;20;34;82;932;31;82;0,40;27,41;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
572;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0,166;Q3;9;35;81;195;6;80;0,06;5,57;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
573;21412;Zeitschrift fr Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0,166;Q4;12;52;198;621;21;138;0,19;11,94;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
574;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0,164;Q3;8;22;59;610;23;59;0,35;27,73;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q3)
575;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0,164;Q3;12;16;33;449;9;24;0,38;28,06;United Kingdom;BioMed Central;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
576;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0,164;Q3;14;72;132;2475;47;131;0,33;34,38;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
577;19500156813;Procedia in Vaccinology;journal;1877282X;0,163;Q3;10;21;110;409;36;109;0,31;19,48;Netherlands;Elsevier BV;2009-2012;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4)"
578;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0,161;Q4;24;32;83;998;29;82;0,32;31,19;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
579;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0,160;Q3;3;41;102;1113;7;101;0,03;27,15;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
580;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0,160;Q3;26;787;2072;8107;641;2071;0,28;10,30;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
581;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;0,159;Q3;9;17;18;264;4;18;0,22;15,53;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
582;19900192163;Results in Pharma Sciences;journal;22112863;0,158;Q3;13;13;11;397;7;11;0,64;30,54;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science (Q3)
583;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0,157;Q4;12;23;77;585;31;72;0,45;25,43;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
584;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0,157;Q3;9;7;34;279;27;32;0,96;39,86;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
585;19700170837;Vitae;journal;01214004;0,157;Q3;11;25;103;944;35;96;0,28;37,76;Colombia;Universidad de Antioquia;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
586;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0,156;Q3;14;11;45;155;11;41;0,20;14,09;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
587;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0,156;Q3;8;103;111;2258;52;107;0,49;21,92;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
588;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0,155;Q3;15;42;115;1197;26;110;0,27;28,50;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
589;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0,155;Q4;9;55;146;1907;37;146;0,23;34,67;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
590;15842;Journal of Applied Research;journal;1537064X;0,153;Q4;18;13;48;366;23;45;0,50;28,15;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
591;19700174997;ONdrugDelivery;trade journal;2049145X;0,152;Q3;5;46;87;120;13;76;0,17;2,61;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q3)
592;21100196907;Open Toxinology Journal;journal;18754147;0,152;Q4;2;0;1;0;1;1;1,00;0,00;United Arab Emirates;Bentham Science Publishers;2011-2013;"Pharmacology (medical) (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
593;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0,150;Q4;7;174;323;3238;41;323;0,12;18,61;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
594;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0,150;Q4;22;11;31;914;13;31;0,55;83,09;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
595;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0,149;Q4;9;6;24;61;2;19;0,08;10,17;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
596;21932;Hindustan Antibiotics Bulletin;journal;00181935;0,149;Q4;8;0;7;0;5;7;0,00;0,00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
597;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0,148;Q3;8;33;81;888;22;71;0,26;26,91;Spain;Real Academia Nacional de Farmacia;2004-2005;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4)"
598;22375;Indian Drugs;journal;0019462X;0,148;Q3;30;84;380;1882;65;380;0,16;22,40;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
599;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0,148;Q4;9;15;68;297;19;68;0,21;19,80;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
600;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0,148;Q3;14;30;80;1429;33;67;0,48;47,63;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
601;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0,147;Q4;9;50;101;1021;31;91;0,36;20,42;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
602;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0,147;Q4;16;23;84;502;23;84;0,22;21,83;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
603;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0,147;Q4;26;165;444;2606;96;394;0,25;15,79;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
604;19700188484;Journal of Bioequivalence and Bioavailability;journal;09750851;0,146;Q3;10;35;58;660;21;54;0,39;18,86;India;OMICS Publishing Group;2011-2014 (cancelled);Pharmaceutical Science (Q3)
605;19408;Actualites Pharmaceutiques;journal;05153700;0,145;Q4;5;143;402;696;14;362;0,05;4,87;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
606;15340;Developments in Biologicals;book series;14246074;0,144;Q4;35;20;1;0;1;1;1,00;0,00;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Biomaterials (Q4); Immunology (Q4); Pharmacology (Q4)"
607;19700170617;EXCLI Journal;journal;16112156;0,144;Q4;24;81;92;3106;176;81;2,69;38,35;Germany;University of Mainz;2009-ongoing;"Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
608;22514;Japanese Journal of Chemotherapy;journal;13407007;0,144;Q4;12;23;123;457;11;123;0,11;19,87;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
609;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0,143;Q3;6;0;31;0;9;31;0,28;0,00;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
610;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0,143;Q4;11;46;109;1022;23;103;0,18;22,22;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
611;19500157008;Fooyin Journal of Health Sciences;journal;18778607;0,142;Q4;5;0;35;0;16;33;0,55;0,00;Netherlands;Elsevier BV;2009-2010;"Medicine (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4)"
612;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0,142;Q4;11;20;51;6;9;51;0,19;0,30;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
613;22338;Hospital Pharmacy;journal;00185787;0,141;Q4;21;132;429;1684;53;360;0,12;12,76;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
614;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0,140;Q4;5;0;11;0;4;11;0,00;0,00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
615;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0,139;Q4;10;27;143;463;38;126;0,22;17,15;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
616;21100804474;European Pharmaceutical Journal;journal;24536725;0,139;Q3;5;27;43;459;3;41;0,14;17,00;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
617;23171;Korean Journal of Pharmacognosy;journal;02533073;0,139;Q3;14;0;166;0;37;166;0,18;0,00;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
618;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0,139;Q4;22;0;72;0;22;72;0,11;0,00;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q4)
619;22979;Journal of Applied Therapeutic Research;journal;10292659;0,138;Q4;7;5;30;206;8;30;0,25;41,20;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
620;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0,138;Q4;8;0;35;0;8;34;0,24;0,00;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
621;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;0,137;Q3;15;149;240;3316;51;239;0,21;22,26;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
622;22906;Journal of China Pharmaceutical University;journal;10005048;0,137;Q3;13;107;312;1706;52;311;0,20;15,94;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
623;19700175137;Trends in Medical Research;journal;18193587;0,137;Q3;8;6;28;350;16;28;0,42;58,33;United States;Academic Journals Inc.;2008-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
624;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;0,136;Q3;6;0;19;0;9;10;0,90;0,00;India;Medknow Publications;2011;Pharmaceutical Science (Q3)
625;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0,136;Q3;9;23;66;547;19;66;0,29;23,78;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
626;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;0,135;Q4;14;36;23;640;6;23;0,26;17,78;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery (Q4)
627;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;0,135;Q3;7;0;26;0;6;26;0,23;0,00;Bangladesh;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science (Q3)
628;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0,134;Q3;10;75;81;2167;21;81;0,26;28,89;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science (Q3)
629;19399;Acta Pharmaceutica Hungarica;journal;00016659;0,133;Q4;12;16;51;478;13;50;0,33;29,88;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
630;73076;Drug Discovery World;journal;14694344;0,133;Q4;10;42;142;503;34;127;0,25;11,98;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
631;21795;Farmaceuticky Obzor;journal;00148172;0,133;Q4;7;34;97;333;5;93;0,05;9,79;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q4)
632;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0,133;Q3;12;30;94;997;13;94;0,10;33,23;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
633;21211;Pharmacy Education;journal;14772701, 15602214;0,133;Q4;15;9;69;196;9;69;0,15;21,78;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
634;5200152604;Pharma Times;journal;00316849;0,133;Q3;10;85;238;441;33;184;0,16;5,19;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
635;21100201517;RSC Drug Discovery Series;book series;20413203;0,133;Q4;7;0;12;0;1;11;0,09;0,00;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery (Q4)
636;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0,132;Q4;9;16;32;273;12;32;0,38;17,06;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q4)
637;19700175002;Pharmaceutical Reviews;journal;19185561;0,132;Q4;4;0;57;0;20;57;0,28;0,00;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
638;20572;PZ Prisma;journal;09455566;0,132;Q4;5;32;104;663;5;91;0,05;20,72;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
639;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0,131;Q4;6;1;13;13;5;12;0,42;13,00;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
640;21102;Pharmaceutical Journal;journal;00316873;0,131;Q4;25;800;2583;360;41;833;0,04;0,45;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
641;21100197929;Toxicological Research;journal;19768257;0,131;Q4;20;40;85;973;11;85;0,12;24,33;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
642;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;00002010;0,130;-;4;0;54;0;15;51;0,29;0,00;United States;;2010;"Molecular Medicine; Pharmacology"
643;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0,130;Q4;13;520;1117;7980;152;1117;0,13;15,35;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
644;9100153105;Current Topics in Pharmacology;journal;09724559;0,130;Q4;4;11;39;637;8;39;0,21;57,91;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
645;21798;Farmaceutski Glasnik;journal;00148202;0,129;Q4;5;69;206;655;6;168;0,03;9,49;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
646;21100244805;Journal of Vaccines and Vaccination;journal;21577560;0,129;Q4;9;54;24;1716;10;23;0,43;31,78;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
647;130170;Phytotherapie;journal;17652847, 16248597;0,129;Q4;12;66;189;1462;22;153;0,15;22,15;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
648;19700174926;International Journal of Health Research;journal;15969819, 15969886;0,128;Q4;7;5;83;110;24;81;0,04;22,00;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
649;9800153137;Trastornos Adictivos;journal;15750973;0,128;Q4;8;19;85;561;10;61;0,16;29,53;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
650;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0,127;Q3;5;15;45;463;10;36;0,30;30,87;Switzerland;Springer International Publishing AG;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
651;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0,125;Q4;8;0;17;0;3;16;0,00;0,00;United Arab Emirates;Bentham Science Publishers;2006-2009;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
652;23107;Journal of Pharmacy Technology;journal;87551225;0,125;Q4;9;35;95;844;12;93;0,09;24,11;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
653;19700174925;European Pharmaceutical Review;trade journal;13608606;0,124;Q3;7;49;102;968;20;94;0,23;19,76;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
654;5200152843;Farmaceutico Hospitales;journal;02144697;0,124;Q4;3;10;39;135;2;25;0,13;13,50;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
655;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0,123;Q4;10;0;45;0;14;44;0,23;0,00;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
656;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;00002010;0,123;-;4;0;50;0;9;48;0,19;0,00;United States;;2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
657;25197;Revista de Toxicologia;journal;16970748, 02127113;0,123;Q4;9;23;38;734;7;38;0,07;31,91;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
658;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0,122;Q4;9;66;149;1280;18;149;0,13;19,39;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
659;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0,122;Q4;14;23;72;764;14;72;0,02;33,22;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
660;22977;Journal de Pharmacie de Belgique;journal;00472166;0,122;Q4;12;33;78;401;9;76;0,14;12,15;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
661;19700177006;Psychopharm Review;trade journal;19369255;0,122;Q4;4;12;36;420;11;36;0,33;35,00;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
662;21100469670;Antibiotics;journal;20796382;0,121;Q3;20;5;1;133;0;1;0,00;26,60;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Infectious Diseases (Q4); Microbiology (Q4); Microbiology (medical) (Q4); Pharmacology (medical) (Q4)"
663;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;0,121;Q3;5;0;1;0;0;1;0,00;0,00;United States;Hindawi Limited;2011, 2014-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Oncology (Q4); Pharmacology (medical) (Q4)"
664;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0,121;Q4;2;1;1;163;0;1;0,00;163,00;India;Open Access Science Research Publisher;2013;"Drug Discovery (Q4); Plant Science (Q4)"
665;21100781436;Journal of Experimental Pharmacology;journal;11791454;0,121;Q4;7;2;1;192;0;1;0,00;96,00;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
666;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0,121;Q4;8;29;83;1205;11;65;0,17;41,55;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
667;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0,120;Q4;13;126;446;3033;25;446;0,06;24,07;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
668;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0,120;Q4;11;144;246;3259;30;246;0,10;22,63;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
669;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0,120;Q3;8;24;27;780;8;27;0,30;32,50;Canada;Lifescience Global;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
670;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0,120;Q4;8;46;82;1083;17;82;0,21;23,54;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
671;21127;Pharmaceutical Technology Europe;journal;17537967;0,120;Q4;16;56;355;185;27;281;0,08;3,30;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
672;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0,119;Q4;13;122;328;2095;47;325;0,10;17,17;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
673;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0,119;Q4;9;19;127;573;19;117;0,01;30,16;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
674;21800;Farmacevtski Vestnik;journal;00148229;0,118;Q4;4;53;150;1515;9;135;0,07;28,58;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
675;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0,118;Q4;4;39;125;1025;16;109;0,17;26,28;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
676;19700175602;Next Generation Pharmaceutical;trade journal;-;0,118;Q4;1;0;221;0;1;132;0,00;0,00;United Kingdom;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
677;19700175039;Open Toxicology Journal;journal;18743404;0,118;Q4;5;2;15;132;7;15;0,38;66,00;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology (Q4)
678;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0,117;Q4;3;0;15;0;2;15;0,00;0,00;Ethiopia;Ethiopian Pharmaceutical Association;2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
679;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;0,117;Q4;6;18;6;563;1;5;0,20;31,28;United Kingdom;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
680;22887;Chinese Journal of Antibiotics;journal;10018689;0,116;Q4;10;179;511;3213;43;508;0,08;17,95;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
681;13000154717;Current Topics in Toxicology;journal;09728228;0,116;Q4;6;8;18;758;2;18;0,15;94,75;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
682;19200156912;EJHP Practice;journal;20303769, 17819989;0,116;Q4;5;0;289;0;37;218;0,15;0,00;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
683;19700201404;Open Drug Safety Journal;journal;18768180;0,116;Q4;3;0;10;0;2;10;0,20;0,00;Netherlands;Bentham Science Publishers B.V.;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
684;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0,116;Q4;5;35;123;210;12;111;0,12;6,00;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
685;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0,115;Q4;13;83;253;1207;23;253;0,12;14,54;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
686;21823;Farmatsija;journal;04280296;0,113;Q4;5;11;30;358;3;30;0,09;32,55;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
687;19700175034;Pharmaceutical Processing;trade journal;10499156;0,113;Q4;2;116;152;194;5;101;0,06;1,67;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
688;22358;U.S. Pharmacist;journal;01484818;0,113;Q4;7;158;416;2469;29;362;0,10;15,63;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
689;21238;Drug Topics;journal;00126616;0,112;Q4;7;230;645;274;7;158;0,06;1,19;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
690;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0,112;Q4;3;27;61;380;7;58;0,15;14,07;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
691;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0,112;Q4;7;37;17;942;1;17;0,06;25,46;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science (Q4)
692;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0,112;Q4;7;12;50;429;14;50;0,24;35,75;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
693;19700175108;Drug Delivery System;journal;09135006;0,111;Q4;7;25;88;766;3;88;0,02;30,64;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
694;21100199794;Industrial Pharmacy;trade journal;17414911;0,111;Q4;4;21;19;156;2;19;0,11;7,43;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science (Q4)
695;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0,111;Q4;5;0;2;0;0;2;0,00;0,00;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
696;23009;Journal of Clinical Research;journal;13695207;0,111;Q4;11;0;2;0;0;2;0,00;0,00;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
697;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0,111;Q4;3;4;2;152;1;2;0,50;38,00;Netherlands;Bentham Science Publishers B.V.;2011-2013;"Economics, Econometrics and Finance (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
698;86349;Oral Therapeutics and Pharmacology;journal;02881012;0,111;Q4;5;12;31;164;2;31;0,09;13,67;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
699;21142;Pharmaceutisch Weekblad;journal;00316911;0,111;Q4;9;417;1221;687;15;934;0,01;1,65;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
700;21243;Pharmacy times;trade journal;00030627;0,111;Q4;8;320;582;1222;9;470;0,02;3,82;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
701;21716;Pharmazeutische Zeitung;journal;00317136;0,111;Q4;7;577;1536;560;9;898;0,01;0,97;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
702;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0,110;Q4;17;109;285;1525;19;273;0,09;13,99;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
703;19700201410;Milestones in Drug Therapy;book series;22966056;0,110;Q4;4;51;59;4172;7;58;0,12;81,80;United States;Springer Science + Business Media;2010-ongoing;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
704;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0,109;Q4;6;22;83;1600;13;83;0,16;72,73;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
705;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0,109;Q4;12;74;248;1128;29;224;0,12;15,24;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
706;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0,108;Q4;23;40;14;1073;3;14;0,21;26,83;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
707;19700174922;Chinese Journal of New Drugs;journal;10033734;0,108;Q4;9;628;1241;9893;74;1241;0,06;15,75;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
708;20543;Pharmacometrics;journal;03008533;0,108;Q4;6;14;55;221;4;55;0,05;15,79;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
709;17716;Quality Assurance Journal;journal;10991786, 10878378;0,108;Q4;7;0;45;0;9;40;0,09;0,00;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
710;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0,108;Q4;14;292;399;6778;22;399;0,06;23,21;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
711;19700174940;SA Pharmaceutical Journal;journal;10151362;0,108;Q4;6;149;479;899;17;293;0,06;6,03;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q4)
712;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;00002010;0,107;-;1;0;33;0;1;32;0,03;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
713;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0,107;Q4;12;63;227;1217;16;227;0,06;19,32;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
714;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0,107;Q4;37;0;6;0;1;6;0,00;0,00;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
715;20628;Circular Farmaceutica;journal;00097314;0,106;Q4;2;30;98;389;1;84;0,02;12,97;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
716;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0,106;Q4;5;0;41;0;5;34;0,15;0,00;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
717;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;00002010;0,105;-;4;0;234;0;15;229;0,07;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
718;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254;0,105;Q4;5;34;19;430;2;18;0,11;12,65;Taiwan;Elsevier Taiwan;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
719;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0,105;Q4;6;17;133;79;8;127;0,05;4,65;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
720;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;00002009;0,104;-;4;0;71;0;8;70;0,00;0,00;United States;;2009;"Molecular Medicine; Pharmacology"
721;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0,104;Q4;3;0;99;0;12;98;0,12;0,00;Poland;Medical University of Silesia;2010-2011;Pharmaceutical Science (Q4)
722;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0,104;Q4;11;30;110;477;4;110;0,04;15,90;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
723;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0,104;Q4;5;0;5;0;0;5;0,00;0,00;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
724;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0,103;Q4;6;36;106;0;1;106;0,00;0,00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
725;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;0,103;Q4;4;16;10;311;0;7;0,00;19,44;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
726;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0,103;Q4;3;37;86;316;4;68;0,04;8,54;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
727;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;0,103;Q4;8;17;6;617;0;6;0,00;36,29;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
728;19700175049;Internet Journal of Toxicology;journal;15593916;0,103;Q4;5;0;41;0;5;41;0,04;0,00;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
729;19700201509;Pharma Research;journal;09758216;0,103;Q4;4;25;46;730;2;45;0,04;29,20;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
730;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;0,103;Q4;3;40;62;760;6;60;0,10;19,00;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
731;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0,102;Q4;2;0;11;0;0;9;0,00;0,00;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
732;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0,102;Q4;4;19;57;350;2;47;0,00;18,42;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
733;19700174886;Arzneimitteltherapie;journal;07236913;0,102;Q4;6;160;419;870;11;206;0,07;5,44;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
734;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0,102;Q4;7;14;59;408;3;59;0,06;29,14;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
735;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0,102;Q4;3;0;374;0;7;370;0,01;0,00;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
736;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0,102;Q4;4;131;336;2095;14;336;0,02;15,99;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
737;50087;EBR - European Biopharmaceutical Review;journal;13690663;0,102;Q4;5;61;178;401;7;177;0,04;6,57;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
738;21867;Geneesmiddelenbulletin;journal;03044629;0,102;Q4;6;65;172;687;3;72;0,08;10,57;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
739;19900192735;International Drug Discovery;journal;21504806, 21504792;0,102;Q4;4;4;28;136;2;28;0,07;34,00;United States;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
740;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0,102;Q4;9;75;440;0;13;401;0,03;0,00;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
741;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0,102;Q4;7;95;323;770;3;313;0,02;8,11;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
742;18098;Japanese Journal of Psychopharmacology;journal;13402544;0,102;Q4;11;0;15;0;0;11;0,00;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
743;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0,102;Q4;7;10;11;306;0;11;0,00;30,60;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
744;13637;Manufacturing Chemist;journal;02624230;0,102;Q4;6;135;291;306;6;265;0,03;2,27;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
745;5000158120;Pharmacy News;journal;1448207X;0,102;Q4;1;0;342;0;2;155;0,02;0,00;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
746;25196;Revista Brasileira de Toxicologia;journal;14152983;0,102;Q4;6;0;12;0;0;12;0,00;0,00;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
747;5800207507;Side Effects of Drugs Annual;book series;03786080;0,102;Q4;5;53;156;4034;4;152;0,02;76,11;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
748;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0,101;Q4;2;3;89;0;3;77;0,05;0,00;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
749;19430;Adverse Drug Reaction Bulletin;journal;00446394;0,101;Q4;7;6;16;222;1;16;0,00;37,00;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
750;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;00002010;0,101;-;1;0;29;0;0;28;0,00;0,00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
751;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;0,101;Q4;8;18;22;408;4;22;0,18;22,67;Turkey;Moment Publications;2011-ongoing;"Analytical Chemistry (Q4); Electrochemistry (Q4); Pharmaceutical Science (Q4); Spectroscopy (Q4)"
752;21100202747;GMP Review;trade journal;14764547;0,101;Q4;2;23;17;87;1;17;0,06;3,78;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science (Q4)
753;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0,101;Q4;5;269;720;3876;9;720;0,01;14,41;China;Jilin University;2005-ongoing;Pharmacology (Q4)
754;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;0,101;Q4;7;28;16;627;3;14;0,21;22,39;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Physiology (Q4)"
755;21100451405;Natural Products Journal;journal;22103163, 22103155;0,101;Q4;9;49;18;1539;0;17;0,00;31,41;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
756;19700175580;PharmacoVigilance Review;journal;17526752;0,101;Q4;1;20;46;70;0;31;0,00;3,50;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
757;21227;Pharmacy in Practice;journal;13581538;0,101;Q4;5;0;26;0;0;23;0,00;0,00;United Kingdom;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
758;19700174966;Pharmakeftiki;journal;11054999;0,101;Q4;2;14;15;672;0;15;0,00;48,00;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
759;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0,101;Q4;2;1;15;24;0;15;0,00;24,00;Russian Federation;SRL Archive;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
760;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;0,101;Q4;4;30;35;1027;2;34;0,06;34,23;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering (Q4); Drug Discovery (Q4)"
761;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;00002009;0,100;-;0;0;44;0;0;42;0,00;0,00;United States;;2009;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
762;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0,100;Q4;9;0;39;0;0;39;0,00;0,00;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
763;19700173109;Contract Pharma;trade journal;15443469;0,100;Q4;3;159;406;148;3;335;0,01;0,93;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
764;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0,100;Q4;3;65;210;163;1;207;0,01;2,51;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
765;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0,100;Q4;4;29;129;752;1;125;0,00;25,93;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
766;5100154302;European Biotechnology Science and Industry News;journal;16188276;0,100;Q4;2;64;112;9;2;90;0,01;0,14;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
767;19700174996;European Life Science Journal;trade journal;20001444;0,100;Q4;1;0;137;0;0;119;0,00;0,00;Thailand;The Psychiatric Association of Thailand;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
768;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0,100;Q4;8;0;88;0;2;88;0,00;0,00;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
769;19700169211;Life Science Clusters;trade journal;17528119;0,100;Q4;0;0;71;0;0;65;0,00;0,00;United Kingdom;Avakado Limited;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
770;21077;Pharmaca;journal;00316857;0,100;Q4;4;0;45;0;0;39;0,00;0,00;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
771;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135;0,100;Q4;1;48;89;271;1;83;0,01;5,65;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-2012;Pharmaceutical Science (Q4)
772;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0,100;Q4;3;64;215;92;3;213;0,02;1,44;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
773;16800154712;Sp2;trade journal;1476184X;0,100;Q4;1;21;189;24;0;169;0,00;1,14;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
774;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0,100;Q4;12;0;192;0;0;181;0,00;0,00;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
775;21100225611;Advanced healthcare materials;journal;21922640, 21922659;;-;63;93;0;5220;0;0;0,00;56,13;United Kingdom;John Wiley and Sons Ltd;2012-ongoing;"Biomaterials; Biomedical Engineering; Pharmaceutical Science"
776;21100219314;Applied and Translational Genomics;journal;22120661;;-;13;8;0;240;0;0;0,00;30,00;Netherlands;Elsevier BV;2012-ongoing;"Biotechnology; Molecular Biology; Pharmaceutical Science"
777;21100228007;Archives of Razi Institute;journal;03653439;;-;5;24;0;572;0;0;0,00;23,83;Iran;Razi Vaccine and Serum Research Institute;2012-ongoing;"Immunology and Microbiology (miscellaneous) ; Toxicology; Veterinary (miscellaneous)"
778;21100218055;BMC pharmacology & toxicology;journal;20506511;;-;23;21;0;746;0;0;0,00;35,52;United Kingdom;BioMed Central;2012-ongoing;"Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
779;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;;-;16;22;0;397;0;0;0,00;18,05;United States;Wiley-Blackwell;2012-ongoing;"Pharmaceutical Science; Pharmacology (medical)"
780;21100782803;Current Psychopharmacology;journal;22115560, 22115579;;-;3;1;0;69;0;0;0,00;69,00;Netherlands;Bentham Science Publishers B.V.;2012, 2015-ongoing;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
781;21100202909;Drug Invention Today;journal;09757619;;-;12;90;0;2205;0;0;0,00;24,50;India;Association of Pharmaceutical Innovators;2012-ongoing;Drug Discovery
782;4700152278;Drugs in Context;journal;17404398, 17451981;;-;12;3;0;310;0;0;0,00;103,33;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine; Pharmacology"
783;21100232818;Emerging Microbes and Infections;journal;22221751;;-;31;29;0;1441;0;0;0,00;49,69;United Kingdom;Nature Publishing Group;2012-ongoing;"Drug Discovery; Epidemiology; Immunology; Infectious Diseases; Medicine (miscellaneous); Microbiology; Parasitology; Virology"
784;21100223537;European Journal of Hospital Pharmacy: Science and Practice;journal;20479956, 20479964;;-;11;139;0;1103;0;0;0,00;7,94;Belgium;European Association of Hospital Pharmacists (EAHP);2012-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
785;21100258853;F1000Research;journal;20461402;;-;32;47;0;1266;0;0;0,00;26,94;United Kingdom;F1000 Research Ltd.;2012-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Immunology and Microbiology (miscellaneous) ; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
786;21100225613;Human gene therapy methods;journal;19466536, 19466544;;-;20;39;0;1614;0;0;0,00;41,38;United States;Mary Ann Liebert Inc.;2012-ongoing;"Applied Microbiology and Biotechnology; Genetics; Genetics (clinical); Molecular Medicine; Pharmacology"
787;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;;-;43;350;0;12270;0;0;0,00;35,06;United States;Landes Bioscience;2012-ongoing;"Immunology; Immunology and Allergy; Medicine (miscellaneous); Pharmacology"
788;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;;-;8;15;0;389;0;0;0,00;25,93;Italy;Scuola IaD;2015-ongoing;"Architecture; Computer Science Applications; Human-Computer Interaction; Media Technology; Pharmacology; Social Sciences (miscellaneous)"
789;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;;-;3;2;0;12;0;0;0,00;6,00;United Kingdom;Taylor and Francis Inc.;2011-2014;"Biomedical Engineering; Chemistry (miscellaneous); Electrical and Electronic Engineering; Materials Science (miscellaneous); Medicine (miscellaneous); Pharmaceutical Science"
790;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;;-;1;1;0;11;0;0;0,00;11,00;India;IJLBPR Editorial Office;2012, 2014, 2016-ongoing;"Applied Microbiology and Biotechnology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
791;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;;-;1;1;0;20;0;0;0,00;20,00;India;International Journal of Pharma Medicine and Biological Sciences;2012, 2016-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
792;21100293201;International Journal of Research in Ayurveda and Pharmacy;journal;22774343, 22293566;;-;8;194;0;3847;0;0;0,00;19,83;India;Moksha Publishing House;2012-2016 (cancelled);"Drug Discovery; Pharmaceutical Science"
793;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;;-;16;48;0;1219;0;0;0,00;25,40;Netherlands;Springer Netherlands;2012-ongoing;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;;-;5;16;0;389;0;0;0,00;24,31;Iran;Kermanshah University of Medical Sciences;2012-ongoing;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
795;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;243;632;5593;223;632;0,32;23,02;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
796;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;;-;6;45;0;2843;0;0;0,00;63,18;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
797;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;;-;43;64;0;2413;0;0;0,00;37,70;United States;Cell Press;2012-ongoing;"Drug Discovery; Molecular Medicine"
798;21100318814;Pharmaceutical patent analyst;journal;20468962;;-;13;42;0;442;0;0;0,00;10,52;United Kingdom;Future Science;2012-ongoing;"Drug Discovery; Medicine (miscellaneous); Pharmaceutical Science"
799;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;;-;58;10;0;1845;0;0;0,00;184,50;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry; Medicine (miscellaneous); Pharmacology; Physiology; Physiology (medical)"
800;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;;-;8;17;0;1143;0;0;0,00;67,24;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery; Organic Chemistry"
801;19700180785;Studies in Natural Products Chemistry;book series;15725995;;-;33;40;0;4190;0;0;0,00;104,75;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery; Organic Chemistry"
802;21100207003;Theranostics;journal;18387640;;-;69;106;0;6517;0;0;0,00;61,48;Canada;Ivyspring International Publisher;2012-ongoing;"Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
803;21100241601;Toxicology Research;journal;2045452X;;-;24;23;0;1605;0;0;0,00;69,78;United Kingdom;Royal Society of Chemistry;2012-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
804;21100208082;VacciMonitor;journal;10250298, 1025028X;;-;3;22;0;436;0;0;0,00;19,82;Cuba;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-ongoing;"Drug Discovery; Immunology; Immunology and Allergy; Molecular Medicine"
805;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;;-;12;43;0;1089;0;0;0,00;25,33;United States;Elsevier USA;2012-ongoing;"Economics, Econometrics and Finance (miscellaneous); Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
